Navana CNG Limited (DSE:NAVANACNG)

CTI BioPharma Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	1,685	1,624	2,032	2,223	2,433	2,261
Market Cap Growth	-20.76%	-20.07%	-8.59%	-8.61%	7.58%	-26.17%
Enterprise Value	13,704	12,590	12,162	11,590	11,189	10,320
Last Close Price	22.30	20.59	24.71	26.52	28.60	25.86
PE Ratio	212.18	233.00	206.21	198.67	163.11	36.55
PS Ratio	0.39	0.40	0.50	0.52	0.48	0.38
PB Ratio	0.72	0.69	0.85	0.92	1.01	0.93
P/TBV Ratio	0.73	0.69	0.86	0.93	1.01	0.94
P/FCF Ratio	-	-	-	12.04	23.70	6.60
P/OCF Ratio	43.16	17.95	43.57	9.07	15.03	3.38
EV/Sales Ratio	3.17	3.09	2.97	2.73	2.23	1.74
EV/EBITDA Ratio	15.53	14.01	13.32	11.54	10.68	8.48
EV/EBIT Ratio	25.82	23.89	23.64	23.37	22.92	16.13
EV/FCF Ratio	-65.38	-	-	62.76	109.00	30.10
Debt / Equity Ratio	5.26	4.83	4.41	4.07	3.78	3.54
Debt / EBITDA Ratio	13.87	12.68	11.59	9.70	8.63	7.08
Debt / FCF Ratio	-	-	-	53.04	89.02	25.23
Asset Turnover	0.29	0.29	0.30	0.33	0.40	0.49
Inventory Turnover	1.10	0.96	1.03	1.16	1.63	2.24
Quick Ratio	0.82	0.84	0.70	0.64	0.31	0.26
Current Ratio	2.25	2.35	2.05	2.00	1.07	0.93
Return on Equity (ROE)	0.34%	0.29%	0.41%	0.46%	0.61%	2.54%
Return on Assets (ROA)	2.24%	2.31%	2.36%	2.38%	2.43%	3.28%
Return on Capital (ROIC)	2.36%	2.46%	2.55%	2.61%	2.69%	3.71%
Return on Capital Employed (ROCE)	4.60%	4.70%	4.80%	4.80%	6.20%	8.40%
Earnings Yield	0.47%	0.43%	0.48%	0.50%	0.61%	2.74%
FCF Yield	-12.44%	-3.47%	-2.06%	8.31%	4.22%	15.16%
Dividend Yield	4.48%	4.86%	4.05%	1.80%	1.59%	1.75%
Payout Ratio	384.60%	544.01%	208.23%	171.67%	285.99%	68.56%
Total Shareholder Return	4.48%	4.86%	4.05%	1.80%	1.59%	1.75%

Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.